Core Insights - Quest Diagnostics (DGX) has announced a collaboration with Epic to enhance laboratory testing experiences for healthcare providers and patients in the U.S. [1][9] Collaboration Details - The partnership, named Project Nova, is a multi-year initiative aimed at streamlining customer-facing processes across all EHR platforms by utilizing Epic's Diagnostic Enterprise system [2][9] - The implementation will focus on consolidating technologies to improve operational agility, efficiency, and quality, including account onboarding, lab ordering, results reporting, appointment scheduling, billing, and customer service [3] Patient Experience Enhancement - The initiative aims to enhance the patient experience through solutions like MyChart, which will provide greater transparency in health plan reimbursement and simplify appointment scheduling at Quest's 2,000 patient service centers across the U.S. [3][9] Industry Prospects - The global clinical laboratory tests market is projected to reach $213.04 billion by 2030, with a CAGR of 8.88% from 2025 to 2030, driven by rising life expectancy and increasing demand for diagnostic testing [4] Additional Updates - Haystack Oncology, a Quest Diagnostics company, has collaborated with the Rutgers Cancer Institute to evaluate a highly sensitive ctDNA MRD test for optimizing postoperative therapy in stage II/III non-small cell lung cancer patients [5] - Quest Diagnostics has also formed a joint venture with Corewell Health to expand access to innovative and affordable laboratory services in Michigan [6]

Core Insights - Quest Diagnostics and Epic have announced a collaboration aimed at enhancing the laboratory testing experience for healthcare providers and patients in the United States [1][2][3] Group 1: Collaboration Details - The partnership will support Project Nova, a multi-year initiative by Quest to simplify and improve customer-facing processes, enhancing experiences for patients and providers across various EHR platforms [2][5] - Epic's Diagnostic Enterprise system will be integrated into Quest's national laboratory operations, including technologies like Aura, Beaker Laboratory, and MyChart [2][3] Group 2: Expected Benefits - Customers can expect faster and more convenient services, improved access to health insights, and quicker turnaround times for testing services [4][7] - The collaboration aims to streamline systems related to lab ordering, results reporting, and patient appointment scheduling, enhancing overall operational efficiency [7] Group 3: Leadership and Implementation - A cross-organization team experienced in large-scale implementations will oversee a phased rollout, ensuring a smooth transition for health systems and providers [5] - The focus will be on creating a comprehensive test list and improving patient engagement through MyChart [3][5]